Scarica l'app Stockscreener
41.60
1.86%
0.76
Pre-mercato:
41.74
0.14
+0.34%
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Edgewise Therapeutics Inc (EWTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edgewise Therapeutics Inc (EWTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edgewise Therapeutics Inc (EWTX) Balance Sheet - TradingKey
Edgewise Therapeutics Inc (EWTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Edgewise Therapeutics, Inc. Revenue Breakdown – NASDAQ:EWTX - TradingView
Edgewise Therapeutics Inc (EWTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edgewise Therapeutics Inc (EWTX) Institutional Confidence - TradingKey
EWTX|Edgewise Therapeutics Inc|Price:41.590|Chg%:+0.750 - TradingKey
TradingKey - TradingKey
EWTX|Edgewise Therapeutics Inc|Price:40.840|Chg%:+1.550 - TradingKey
Is Edgewise Therapeutics (EWTX) on the Cusp of a Breakthrough Year - Kavout | AI
Edgewise Therapeutics, Inc. (EWTX) options chain - Yahoo Finance Singapore
Edgewise Therapeutics, Inc. (EWTX) stock price, news, quote and history - Yahoo Finance UK
Edgewise Therapeutics (EWTX) Trades At A Rich P B, Is The Premium Justified? - Yahoo Finance
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Biotechnology Innovator with a Promising 28.63% Upside - DirectorsTalk Interviews
EWTX Maintained by Evercore ISI Group -- Price Target Raised to $55 - GuruFocus
Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $55 - Moomoo
CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits
(EWTX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Form 4 Edgewise Therapeutics Inc For: 17 July By Investing.com - Investing.com Nigeria
Edgewise Therapeutics director gets 16,377 options | EWTX Insider Trading - Stock Titan
Edgewise Therapeutics (NASDAQ: EWTX) books big gain on $1.55B sevasemten sale - Stock Titan
Frontier tech research, news & data - MLQ.ai
Servier completes the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business - Macau Business
Boulder biotech unloads muscular dystrophy drug for up to $2.65 billion - The Business Journals
Edgewise closes muscular-dystrophy biz sale in deal that could top $2.6M - BizWest
Edgewise sells sevasemten business for $1.55 billion - grafa.com
Edgewise Therapeutics Sells Sevasemten for Up to $2.65 Billion to Focus on Cardiovascular Drug Pipeline - Minichart
Positive Trial Results Propel Edgewise's (EWTX) Plans for Phase 3 Development - GuruFocus
Servier completes $2.65 billion Edgewise muscular dystrophy buy By Investing.com - Investing.com Nigeria
Edgewise Therapeutics Completes Up to $2.65 Billion Sevasemten Sale to Focus on Cardiovascular Pipeline - citybiz
Edgewise completes sale of sevasemten to Servier for $2.65B By Investing.com - Investing.com Nigeria
Servier completes $2.65 billion Edgewise muscular dystrophy buy - Investing.com
Servier Acquires Muscular Dystrophy Business from Edgewise Therapeutics - Contract Pharma
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business - The Manila Times
symbol__ Stock Quote Price and Forecast - CNN
Edgewise (Nasdaq: EWTX) receives $1.55B upfront, pivots to heart drugs - Stock Titan
Edgewise Therapeutics Stock Rides A 5-Day Winning Streak To A 23% Gain - Trefis
Oppenheimer Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $51 - Moomoo
Servier Pharmaceuticals LLC completed the acquisition of Sevasemten and Muscular Dystrophy Business of Edgewise Therapeutics, Inc.. - marketscreener.com
Oppenheimer Initiates Edgewise Therapeutics at Outperform - Moomoo
EWTX Initiated Coverage by Oppenheimer -- Rating Set to Outperfo - GuruFocus
Edgewise Therapeutics' EDG-7500 Seen Entering 'Catalyst-Dense' Regulatory Period, Oppenheimer Says - Moomoo
Oppenheimer initiates Edgewise Therapeutics stock with outperform rating By Investing.com - Investing.com India
Oppenheimer initiates Edgewise Therapeutics stock with outperform rating - Investing.com
Price to book forward of Edgewise Therapeutics, Inc. – NASDAQ:EWTX - TradingView
Edgewise Therapeutics stock hits all-time high at 43.96 USD - Investing.com UK
Edgewise Therapeutics stock hits all-time high at 43.96 USD By Investing.com - Investing.com South Africa
1.97%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):